.

Pharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

DrugPatentWatch Database Preview

KENALOG Drug Profile

« Back to Dashboard

Which patents cover Kenalog, and what substitute generic drugs are available?

Kenalog is a drug marketed by Mylan Pharms Inc, Delcor Asset Corp, Ranbaxy Labs Ltd, and Apothecon. and is included in ten NDAs.

The generic ingredient in KENALOG is triamcinolone acetonide. There are forty-nine drug master file entries for this compound. Seventy-nine suppliers are listed for this compound. Additional details are available on the triamcinolone acetonide profile page.

Summary for Tradename: KENALOG

Patents:0
Applicants:4
NDAs:10
Suppliers / Packagers: see list1
Clinical Trials: see list25
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:KENALOG at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Pharms Inc
KENALOG
triamcinolone acetonide
OINTMENT;TOPICAL011600-003Approved Prior to Jan 1, 1982RXNoNo► Subscribe► Subscribe
Delcor Asset Corp
KENALOG
triamcinolone acetonide
LOTION;TOPICAL084343-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Delcor Asset Corp
KENALOG
triamcinolone acetonide
LOTION;TOPICAL011602-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe
Apothecon
KENALOG-40
triamcinolone acetonide
INJECTABLE;INJECTION014901-001Approved Prior to Jan 1, 1982RXYesYes► Subscribe► Subscribe
Delcor Asset Corp
KENALOG
triamcinolone acetonide
LOTION;TOPICAL084343-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc